Statistics for Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer
Total visits
| views | |
|---|---|
| Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer | 171 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| 41467_2019_Article_11729.pdf | 194 |
| java.util.UUID:e2ad769b-5650-43b9-89ef-951bccd5c4fe | 46 |
| java.util.UUID:1c72ac08-546c-4162-8a0e-82aa4fb4c1f9 | 8 |
| java.util.UUID:6223d798-e4e6-48d0-8e48-7d9caabd454f | 8 |
Top country views
| views | |
|---|---|
| United States | 136 |
| Ukraine | 5 |
| China | 4 |
| Germany | 4 |
| United Kingdom | 2 |
| Vietnam | 2 |
| Canada | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 47 |
| Fairfield | 17 |
| Houston | 14 |
| Cambridge | 6 |
| Ann Arbor | 5 |
| Jacksonville | 5 |
| Kiev | 5 |
| Kiez | 3 |
| Lanham | 3 |
| San Francisco | 3 |
| Dong Ket | 2 |
| Beijing | 1 |
| Brooklyn | 1 |
| Chengdu | 1 |
| Gunzenhausen | 1 |
| Indianapolis | 1 |
| Lake Mary | 1 |
| Mountain View | 1 |
| Scottsdale | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Shenzhen | 1 |
| Toronto | 1 |